Valuation: Immunovia AB

Market Cap 124M 12.84M 11.25M 10.45M 9.6M 18.09M 1.24B 18.35M 48.71M 606M 48.21M 47.17M 2.09B P/E 2026 *
-1.85x
P/E 2027 * -4.63x
Enterprise Value 57.44M 5.93M 5.19M 4.82M 4.43M 8.35M 572M 8.47M 22.48M 280M 22.25M 21.77M 967M EV / Sales 2026 *
18x
EV / Sales 2027 * 2.92x
Free-Float
89.3%
Yield 2026 *
-
Yield 2027 * -
1 day-1.08%
1 week-5.38%
Current month-6.15%
1 month-8.50%
3 months-8.50%
6 months-10.51%
Current year-19.38%
1 week 0.18
Extreme 0.175
0.19
1 month 0.18
Extreme 0.175
0.21
Current year 0.15
Extreme 0.1502
0.25
1 year 0.15
Extreme 0.1502
0.97
3 years 0.15
Extreme 0.1502
4.73
5 years 0.15
Extreme 0.1502
141.5
10 years 0.15
Extreme 0.1502
298.5
Manager TitleAgeSince
Chief Executive Officer 53 2023-04-28
Chief Tech/Sci/R&D Officer 55 2024-04-28
Chief Tech/Sci/R&D Officer 54 2024-01-30
Director TitleAgeSince
Director/Board Member 72 2016-12-08
Chairman 69 2023-05-25
Director/Board Member 51 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
11/15/22 Buy

Chief Executive Officer

150,000 0.6628%
5/24/22 Buy

Chief Executive Officer

100,000 0.4419%
5/21/22 Buy

Chief Executive Officer

100,000 0.4419%
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%-5.38%-59.78%-84.62% 12.84M
+1.89%-10.55%+15.59%-38.32% 15.47B
+1.96%-0.64%+4.02%+95.77% 1.59B
-1.64%-11.19%-36.61%-81.66% 1.12B
+0.86%-1.12%-34.39%+18.38% 1B
-0.66%-1.86%-31.07%-54.19% 631M
-2.23%-9.52%-46.52%-57.97% 516M
-0.28%-1.25%+40.57%-53.97% 452M
-1.61%-3.32%-54.58%-60.97% 378M
-1.80%+5.02%-17.61%-38.31% 356M
Average -0.42%-4.00%-22.04%-35.59% 2.15B
Weighted average by Cap. +1.28%-10.46%+5.53%-29.70%

Financials

2026 *2027 *
Net sales 3.2M 330K 289K 269K 247K 465K 31.87M 472K 1.25M 15.59M 1.24M 1.21M 53.86M 17.3M 1.79M 1.56M 1.45M 1.33M 2.51M 172M 2.55M 6.77M 84.3M 6.7M 6.56M 291M
Net income -91M -9.39M -8.23M -7.64M -7.02M -13.23M -906M -13.42M -35.62M -443M -35.25M -34.49M -1.53B -82M -8.46M -7.41M -6.88M -6.33M -11.92M -817M -12.09M -32.09M -400M -31.77M -31.08M -1.38B
Net Debt -67M -6.91M -6.06M -5.62M -5.17M -9.74M -667M -9.88M -26.22M -326M -25.96M -25.4M -1.13B -74M -7.64M -6.69M -6.21M -5.71M -10.76M -737M -10.91M -28.96M -361M -28.67M -28.05M -1.25B
Logo Immunovia AB
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
Employees
17
Date Price Change Volume
26-07-22 SEK 0.1830 -1.08% 2,597,539
26-07-21 SEK 0.1850 +0.65% 386,788
26-07-20 SEK 0.1838 -0.54% 918,126
26-07-17 SEK 0.1848 -1.28% 1,087,469
26-07-16 SEK 0.1872 -3.21% 2,347,901

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMMNOV Stock